SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:
SEC Accession No. 0001493152-18-004425
Filing Date
2018-04-02
Accepted
2018-04-02 13:33:23
Documents
1
Period of Report
2017-12-31
Effectiveness Date
2018-04-02

Document Format Files

Seq Description Document Type Size
1 nt10-k.htm NT 10-K 31932
  Complete submission text file 0001493152-18-004425.txt   33287
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: NT 10-K | Act: 34 | File No.: 000-52218 | Film No.: 18728139
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences